VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies

被引：46

作者：

Eriksson, U ^{[1
]}

Alitalo, K

机构：

[1] Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden

[2] Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland

[3] Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland

[4] Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland

来源：

NATURE MEDICINE | 2002年 / 8卷 / 08期

关键词：

D O I：

10.1038/nm0802-775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Efforts to control vessel growth have focused on vascular endothelial growth factor ( VEGF) and its primary receptor VEGFR-2. New data could shift that focus to other members of the VEGF family and the receptor VEGFR-1, particularly in inflammatory diseases ( pages 831 - 840 841 - 849).

引用

页码：775 / 777

页数：3

共 18 条

[1] Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect
Aase, K
von Euler, G
Li, X
Pontén, A
Thorén, P
Cao, R
Cao, Y
Olofsson, B
Gebre-Medhin, S
Pekny, M
Alitalo, K
Betsholtz, C
Eriksson, U
[J]. CIRCULATION, 2001, 104 (03) : 358 - 364
[2] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G
Brekken, R
McMahon, G
Vu, TH
Itoh, T
Tamaki, K
Tanzawa, K
Thorpe, P
Itohara, S
Werb, Z
Hanahan, D
[J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
[3] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Carmeliet, P
Moons, L
Luttun, A
Vincenti, V
Compernolle, V
De Mol, M
Wu, Y
Bon, F
Devy, L
Beck, H
Scholz, D
Acker, T
DiPalma, T
Dewerchin, M
Noel, A
Stalmans, I
Barra, A
Blacher, S
Vandendriessche, T
Ponten, A
Eriksson, U
Plate, KH
Foidart, JM
Schaper, W
Charnock-Jones, DS
Hicklin, DJ
Herbert, JM
Collen, D
Persico, MG
[J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
[4] Angiogenesis in cancer and other diseases
Carmeliet, P
Jain, RK
[J]. NATURE, 2000, 407 (6801) : 249 - 257
[5] Developmental control of blood cell migration by the Drosophila VEGF pathway
Cho, NK
Keyes, L
Johnson, E
Heller, J
Ryner, L
Karim, F
Krasnow, MA
[J]. CELL, 2002, 108 (06) : 865 - 876
[6] Angiogenesis therapy - Amidst the hype, the neglected potential for serious side effects
Epstein, SE
Kornowski, R
Fuchs, S
Dvorak, HF
[J]. CIRCULATION, 2001, 104 (01) : 115 - 119
[7] Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41
[8] The biology of vascular endothelial growth factor
Ferrara, N
DavisSmyth, T
[J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
[9] Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N
Alitalo, K
[J]. NATURE MEDICINE, 1999, 5 (12) : 1359 - 1364
[10] Fong GH, 1999, DEVELOPMENT, V126, P3015

← 1 2 →